Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Ledipasvir/Sofosbuvir in Pregnant Women with HCV
NCT02683005Phase 1Completed
- Start
- Sep 2016
- Primary completion
- Feb 2020
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Harvoni in hepatitis C (HCV). Primary endpoint: Area Under Curve. Started Sep 2016; status: completed.
02
Drugs
Harvoni
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02683005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02683005.